665 related articles for article (PubMed ID: 14644723)
1. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Nakazawa T; Kano T; Ohta S; Tamai M
Ophthalmology; 2003 Dec; 110(12):2386-94. PubMed ID: 14644723
[TBL] [Abstract][Full Text] [Related]
2. Changes in macular thickness after panretinal photocoagulation in patients with severe diabetic retinopathy and no macular edema.
Lee SB; Yun YJ; Kim SH; Kim JY
Retina; 2010 May; 30(5):756-60. PubMed ID: 20453801
[TBL] [Abstract][Full Text] [Related]
3. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Nakazawa T; Tamai M
Am J Ophthalmol; 2005 Jul; 140(1):8-15. PubMed ID: 15939392
[TBL] [Abstract][Full Text] [Related]
4. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
5. Temporal variation in diabetic macular edema measured by optical coherence tomography.
Frank RN; Schulz L; Abe K; Iezzi R
Ophthalmology; 2004 Feb; 111(2):211-7. PubMed ID: 15019364
[TBL] [Abstract][Full Text] [Related]
6. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
Kim SJ; Equi R; Bressler NM
Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
Mason JO; Yunker JJ; Vail R; McGwin G
Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
[TBL] [Abstract][Full Text] [Related]
8. Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy.
Takahashi A; Nagaoka T; Sato E; Yoshida A
Br J Ophthalmol; 2008 Oct; 92(10):1369-73. PubMed ID: 18662912
[TBL] [Abstract][Full Text] [Related]
9. [Panretinal photocoagulation with or without focal photocoagulation--the effect on central retinal thickness].
Danielescu C; Chiseliţă D
Oftalmologia; 2010; 54(2):99-103. PubMed ID: 20827919
[TBL] [Abstract][Full Text] [Related]
10. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
Yanyali A; Nohutcu AF; Horozoglu F; Celik E
Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
Margolis R; Singh RP; Bhatnagar P; Kaiser PK
Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
[TBL] [Abstract][Full Text] [Related]
12. Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery.
Suto C; Hori S; Kato S
J Cataract Refract Surg; 2008 Jun; 34(6):1001-6. PubMed ID: 18499009
[TBL] [Abstract][Full Text] [Related]
13. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
Browning DJ; Fraser CM; Clark S
Ophthalmology; 2008 Mar; 115(3):533-539.e2. PubMed ID: 18067962
[TBL] [Abstract][Full Text] [Related]
14. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
Cho WB; Oh SB; Moon JW; Kim HC
Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
[TBL] [Abstract][Full Text] [Related]
15. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.
Recchia FM; Ruby AJ; Carvalho Recchia CA
Am J Ophthalmol; 2005 Mar; 139(3):447-54. PubMed ID: 15767052
[TBL] [Abstract][Full Text] [Related]
16. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
Wilczyński M; Dzivgielewski K
Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema.
Figueira J; Khan J; Nunes S; Sivaprasad S; Rosa A; de Abreu JF; Cunha-Vaz JG; Chong NV
Br J Ophthalmol; 2009 Oct; 93(10):1341-4. PubMed ID: 19054831
[TBL] [Abstract][Full Text] [Related]
19. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
20. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.
Lee CM; Olk RJ; Akduman L
Ophthalmic Surg Lasers; 2000; 31(4):292-300. PubMed ID: 10928666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
